Citations

Clear

1053 citation(s) found for "Andre, F".

Inspiratory function of the levator costae and external intercostal muscles in the dog
Troyer, André De, Farkas, G. A.

Mayo Clinic

Journal of Applied Physiology | December 21, 2017 | Volume: 67 | Issue: 6 | Pages: 2614-2621

10.1152/jappl.1989.67.6.2614 | PMID 2606869 Get It

The shortening of the canine parasternal intercostals during inspiration may have a passive component, and we have previously speculated that this might result from the actions of the levator costae and external intercostals (J. Appl. Physiol. 66: 1421-1429, 1989). The present studies were designed, therefore, to evaluate the pattern of activation of these muscles in the dog and to define their action on the rib cage during breathing. The results indicate that 1) the levator costae and external intercostals in the cranial part of the rib cage are active during inspiration, both in the supine and in the prone posture; 2) the inspiratory activation of the two muscles is increased after bilateral phrenicotomy; 3) it is increased even more when the parasternal intercostals in the different interspaces are also denervated; and 4) when the levator costae and external intercostals are the only muscles active during inspiration, the ribs continue to move cranially, and the sternum, rather than moving caudally as it does in the intact animal, moves cranially as well. Therefore, we conclude that the levator costae and external intercostals in the dog have a true inspiratory function. When needed, they are capable of causing a significant expansion of the rib cage and the lung during breathing.
Mechanical arrangement of the parasternal intercostals in the different interspaces
Troyer, André De, Farkas, G. A.

Mayo Clinic

Journal of Applied Physiology | December 21, 2017 | Volume: 66 | Issue: 3 | Pages: 1421-1429

10.1152/jappl.1989.66.3.1421 | PMID 2708257 Get It

When the parasternal intercostal in a single interspace is selectively denervated in dogs with diaphragmatic paralysis, it continues to shorten during both quiet and occluded inspiration. In the present studies, we have tested the hypothesis that this passive parasternal inspiratory shortening is due to the action of the other parasternal intercostals. Changes in length of the denervated third right parasternal were measured in eight supine phrenicotomized animals. We found that 1) the inspiratory muscle shortening increased after denervation of the third left parasternal but gradually decreased with denervation of the parasternals situated in the second, fourth, and fifth interspaces; 2) the muscle, however, always continued to shorten during inspiration, even after denervation of all the parasternals; 3) stimulating selectively the third left parasternal caused a muscle lengthening; and 4) bilateral stimulation of the parasternals in the second or the fourth interspace produced a muscle shortening. We conclude that 1) the two parasternals situated in the same interspace on both sides of the sternum are mechanically arranged in series, whereas the parasternals located in adjacent interspaces are mechanically arranged in parallel; and 2) if a denervated parasternal continues to shorten during inspiration, this is in part because of the action of the parasternals in the adjacent interspaces and in part because of other inspiratory muscles of the rib cage, possibly the external intercostals and the levator costae.
Passive shortening of canine parasternal intercostals during breathing
Troyer, André De, Farkas, G. A.

Mayo Clinic

Journal of Applied Physiology | December 21, 2017 | Volume: 66 | Issue: 3 | Pages: 1414-1420

10.1152/jappl.1989.66.3.1414 | PMID 2708256 Get It

We have previously demonstrated that the shortening of the canine parasternal intercostals during inspiration results primarily from the muscles' own activation (J. Appl. Physiol. 64: 1546–1553, 1988). In the present studies, we have tested the hypothesis that other inspiratory rib cage muscles may contribute to the parasternal inspiratory shortening. Eight supine, spontaneously breathing dogs were studied. Changes in length of the third or fourth right parasternal intercostal were measured during quiet breathing and during single-breath airway occlusion first with the animal intact, then after selective denervation of the muscle, and finally after bilateral phrenicotomy. Denervating the parasternal virtually eliminated the muscle shortening during quiet inspiration and caused the muscle to lengthen during occluded breaths. After phrenicotomy, however, the parasternal, while being denervated, shortened again a significant amount during both quiet inspiration and occluded breaths. These data thus confirm that a component of the parasternal inspiratory shortening is not active and results from the action of other inspiratory rib cage muscles. Additional studies in four animals demonstrated that the scalene and serratus muscles do not play any role in this phenomenon; it must therefore result from the action of intrinsic rib cage muscles.
Linkage between parasternals and external intercostals during resting breathing
Troyer, André De, Farkas, G. A.

Mayo Clinic

Journal of Applied Physiology | December 21, 2017 | Volume: 69 | Issue: 2 | Pages: 509-516

10.1152/jappl.1990.69.2.509 | PMID 2228860 Get It

To assess the mechanical coupling between the parasternal and external intercostals in the cranial portion of the rib cage, we measured the respiratory changes in length and the electromyograms of the two muscles in the same third or fourth intercostal space in 24 spontaneously breathing dogs. We found that 1) the amount of inspiratory shortening of the external intercostal was considerably smaller than the amount of shortening of the parasternal; 2) after selective denervation of the parasternal, the inspiratory shortening of both the parasternal and the external intercostal was almost abolished; 3) on the other hand, after selective denervation of the external intercostal, the inspiratory shortening of the parasternal was unchanged, and the inspiratory shortening of the external intercostal was reduced but not suppressed; and 4) this persistent shortening of the external intercostal was reversed into a clear-cut inspiratory lengthening when the parasternal was subsequently denervated. We conclude that in the dog 1) the inspiratory contraction of the external intercostals in the cranial portion of the rib cage is agonistic in nature as is the contraction of the parasternals; 2) during resting breathing, however, the changes in length of these external intercostals are largely determined by the action of the parasternals. These observations are consistent with the idea that in the dog, the parasternals play a larger role than the external intercostals in elevating the ribs during resting inspiratio
Effects of midline laparotomy on expiratory muscle activation in anesthetized dogs
Farkas, G. A., Troyer, André De

Mayo Clinic

Journal of Applied Physiology | December 21, 2017 | Volume: 67 | Issue: 2 | Pages: 599-605

10.1152/jappl.1989.67.2.599 | PMID 2793661 Get It

Abdominal surgery has a marked inhibitory influence on the diaphragm, but its effect on the expiratory muscles is not known. Therefore, we have recorded the electromyograms of the triangularis sterni, abdominal external oblique, and transversus abdominis before and after a midline laparotomy in 10 anesthetized, spontaneously breathing dogs. Measurements were obtained during quiet breathing in the supine posture, during breathing against expiratory threshold loads, during head-up tilting, and during hyperoxic hypercapnia. Expiratory activation of the transversus abdominis in all conditions was considerably reduced after laparotomy. This reduction was real, as no change in the compound muscle action potential during single pulse stimulation was observed. In contrast, expiratory recruitment of either the triangularis sterni or the abdominal external oblique was maintained or increased. We therefore conclude that laparotomy inhibits not only activation of the diaphragm during inspiration but also activation of the transversus abdominis during expiration. Visceral afferents thus affect in concert the two respiratory muscles lining the peritoneum. The present findings also emphasize the important fact that the pattern of activation of a particular abdominal muscle is not necessarily representative of the entire abdominal musculature.
Obesity‐induced mitochondrial dysfunction in porcine adipose tissue‐derived mesenchymal stem cells
Eirin, Alfonso , Zhu, Xiangyang , Chanana, Pritha , Wijnen, André J. van , Lerman, Lilach O. , Meng, Yu , Lerman, Lilach O , van Wijnen, Andre J , Eirin, Alfonso , Tang, Hui Ru , Lerman, Amir

Mayo Clinic

Journal of Cellular Physiology | December 16, 2017 | Volume: 233 | Issue: 8 | Pages: 5926-5936

10.1002/jcp.26402 | PMID 29243809 Get It

Transplantation of autologous mesenchymal stem cells (MSCs) may be a viable option for treatment of several diseases. MSCs efficacy depends on adequate function of their mitochondria, which might be impaired in a noxious milieu. We hypothesized that obesity compromises MSCs mitochondrial structure and function, possibly via micro‐RNA (miRNA)‐based mechanisms. MSCs were collected from swine abdominal adipose tissue after 16 weeks of Lean or Obese diet (n = 7 each). Mitochondrial structure was assessed by electron microscopy and function by membrane potential and cytochrome‐c oxidase (COX)‐IV activity. Oxidative stress was assessed by Mito‐SOX and dihydroethidium staining. Next‐generation sequencing (RNA‐seq) was performed to identify miRNAs expression in MSCs, and predicted mitochondrial target genes were then identified (MitoCarta). Compared to Lean‐MSCs, mitochondria from Obese‐MSCs were smaller and showed cristae remodeling and loss. Mitochondrial membrane potential and COX‐IV activity decreased in Obese‐MSCs, associated with increased mitochondrial oxidative stress. RNA‐seq generated reads for 413 miRNAs, of which 5 miRNAs were upregulated in Obese‐MSCs (fold change >2, p < 0.05) and found to target 43 specific mitochondrial genes. Obesity impairs MSC mitochondrial structure and function, possibly mediated partly through miRNA‐induced mitochondrial gene regulation, leading to increased oxidative stress. Importantly, these alterations may limit the therapeutic use of autologous MSCs in subjects with obesity.
RNA sequencing identifies gene regulatory networks controlling extracellular matrix synthesis in intervertebral disk tissues
Riester, Scott M. , Yang, Lin , Wang, Wei , Lin, Cong , Ali, Abdel‐Moneim Mohamed , Peck, Sun H. , Smith, Lachlan J. , Currier, Bradford L. , Clark, Michelle A. , Huddleston, P.M. , Krauss, William E. , Yaszemski, Michael J. , Bydon, Mohamad , Qu, Wenchun , Wijnen, André J. van , Lin, Yang , Cong, Lin, Mohamed Ali, Abdel-Moneim, Clark, Michelle, Huddleston, Paul, Krauss, William, Larson, Annalise N, van Wijnen, Andre J , Morrey, Mark E. , Abdel, Matthew P. , Larson, A. Noelle , Nassr, Ahmad , Huddleston, Paul M

Mayo Clinic

Journal of Orthopaedic Research | December 11, 2017 | Volume: 36 | Issue: 5 | Pages: 1356-1369

10.1002/jor.23834 | PMID 29227558 Get It

ABSTRACTDegenerative disk disease of the spine is a major cause of back pain and disability. Optimization of regenerative medical therapies for degenerative disk disease requires a deep mechanistic understanding of the factors controlling the structural integrity of spinal tissues. In this investigation, we sought to identify candidate regulatory genes controlling extracellular matrix synthesis in spinal tissues. To achieve this goal we performed high throughput next generation RNA sequencing on 39 annulus fibrosus and 21 nucleus pulposus human tissue samples. Specimens were collected from patients undergoing surgical discectomy for the treatment of degenerative disk disease. Our studies identified associations between extracellular matrix genes, growth factors, and other important regulatory molecules. The fibrous matrix characteristic of annulus fibrosus was associated with expression of the growth factors platelet derived growth factor beta (PDGFB), vascular endothelial growth factor C (VEGFC), and fibroblast growth factor 9 (FGF9). Additionally we observed high expression of multiple signaling proteins involved in the NOTCH and WNT signaling cascades. Nucleus pulposus extracellular matrix related genes were associated with the expression of numerous diffusible growth factors largely associated with the transforming growth signaling cascade, including transforming factor alpha (TGFA), inhibin alpha (INHA), inhibin beta A (INHBA), bone morphogenetic proteins (BMP2, BMP6), and others. Clinical significance: this investigation provides important data on extracellular matrix gene regulatory networks in disk tissues. This information can be used to optimize pharmacologic, stem cell, and tissue engineering strategies for regeneration of the intervertebral disk and the treatment of back pain. © 2017 Orthopaedic Research Society. Published by Wiley Periodicals, Inc. J Orthop Res 36:1356–1369, 2018.
Giant Cell Tumor of Bone in Patients 55 Years and Older
Broehm, Cory , Inwards, Carrie Y., Al‐Ibraheemi, Alyaa , Wenger, Doris E. , Jenkins, Sarah M. , Jin, Long , Oliveira, André M. , Zreik, Riyam , Carter, Jodi M. , Boland, Jennifer M. , Fritchie, Karen , Broehm, Cory J, Fritchie, Karen J. , Carter, Jodi

Mayo Clinic

American Journal of Clinical Pathology | December 6, 2017 | Volume: 149 | Issue: 3 | Pages: 222-233

10.1093/ajcp/aqx155 | PMID 29425276 Get It

International External Validation Study of the 2014 European Society of Cardiology Guidelines on Sudden Cardiac Death Prevention in Hypertrophic Cardiomyopathy (EVIDENCE-HCM)
O’Mahony, Constantinos , Jichi, Fatima, Ommen, Steve R. , Christiaans, Imke , Arbustini, Eloisa , García‐Pavía, Pablo , Olivotto, Iacopo , Kitaoka, Hiroaki , Gotsman, Israel , Carr‐White, Gerald, Mogensen, Jens , Antoniades, Loizos , Tang, Hak Chiaw , Geske, Jeffrey B. , Siontis, Konstantinos C. , Mahmoud, Karim D. , Vermeer, Alexa M.C. , Wilde, Arthur A.M. , Favalli, Valentina , Guttmann, Oliver , Gallego‐Delgado, María , Domínguez, Fernándo , Tanini, Ilaria , Kubo, Toru , Keren, Andre , Bueser, Teofila , Waters, Sarah, Issa, Issa Farah , Malcolmson, James , Burns, Tom, Sekhri, Neha, Hoeger, Christopher W. , Omar, Rumana , Elliott, Perry , Olivotto, Iacopo , Garcia-Pavia, Pablo , Geske, Jeffrey B , Cecchi, Franco , Mohiddin, Saidi , Maurer, Matthew J. , Dominguez, Fernando

Mayo Clinic

Circulation | November 30, 2017 | Volume: 137 | Issue: 10 | Pages: 1015-1023

10.1161/circulationaha.117.030437 | PMID 29191938 Get It

Background: Identification of people with hypertrophic cardiomyopathy (HCM) who are at risk of sudden cardiac death (SCD) and require a prophylactic implantable cardioverter defibrillator is challenging. In 2014, the European Society of Cardiology proposed a new risk stratification method based on a risk prediction model (HCM Risk-SCD) that estimates the 5-year risk of SCD. The aim was to externally validate the 2014 European Society of Cardiology recommendations in a geographically diverse cohort of patients recruited from the United States, Europe, the Middle East, and Asia. Methods: This was an observational, retrospective, longitudinal cohort study. Results: The cohort consisted of 3703 patients. Seventy three (2%) patients reached the SCD end point within 5 years of follow-up (5-year incidence, 2.4% [95% confidence interval {CI}, 1.9–3.0]). The validation study revealed a calibration slope of 1.02 (95% CI, 0.93–1.12), C-index of 0.70 (95% CI, 0.68–0.72), and D-statistic of 1.17 (95% CI, 1.05–1.29). In a complete case analysis (n= 2147; 44 SCD end points at 5 years), patients with a predicted 5-year risk of <4% (n=1524; 71%) had an observed 5-year SCD incidence of 1.4% (95% CI, 0.8–2.2); patients with a predicted risk of ≥6% (n=297; 14%) had an observed SCD incidence of 8.9% (95% CI, 5.96–13.1) at 5 years. For every 13 (297/23) implantable cardioverter defibrillator implantations in patients with an estimated 5-year SCD risk ≥6%, 1 patient can potentially be saved from SCD. Conclusions: This study confirms that the HCM Risk-SCD model provides accurate prognostic information that can be used to target implantable cardioverter defibrillator therapy in patients at the highest risk of SCD.